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Abstract
Genome-wide association studies have been instrumental in identifying genetic variants associated with complex traits such
as human disease or gene expression phenotypes. It has been proposed that extending existing analysis methods by
considering interactions between pairs of loci may uncover additional genetic effects. However, the large number of
possible two-marker tests presents significant computational and statistical challenges. Although several strategies to
detect epistasis effects have been proposed and tested for specific phenotypes, so far there has been no systematic attempt
to compare their performance using real data. We made use of thousands of gene expression traits from linkage and eQTL
studies, to compare the performance of different strategies. We found that using information from marginal associations
between markers and phenotypes to detect epistatic effects yielded a lower false discovery rate (FDR) than a strategy solely
using biological annotation in yeast, whereas results from human data were inconclusive. For future studies whose aim is to
discover epistatic effects, we recommend incorporating information about marginal associations between SNPs and
phenotypes instead of relying solely on biological annotation. Improved methods to discover epistatic effects will result in a
more complete understanding of complex genetic effects.
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Introduction
Genome-wide association studies have been instrumental in
identifying genetic variants associated with complex traits such as
human disease or gene expression phenotypes [1]. However, for
many human traits genetic variants discovered so far account for
only 5–10% of the phenotypic variance [2]. For linkage studies in
yeast, which are grown in tightly controlled environments, the
explained variance of highly heritable gene expression traits is also
limited, with one study reporting a median explained variance of
27% and finding no associated genetic variants for many (40%)
gene expression traits [3]. The challenge of identifying additional
genetic variants which explain a larger proportion of phenotypic
variance is of great interest and has been coined the problem of the
missing heritability [4]. One avenue to discover additional genetic
effects is to consider epistasis, i.e. joint effects between markers.
While many studies have analyzed effects of individual markers,
only recently have studies begun to extend analysis methods to
consider interaction effects between pairs of loci [5–10].
Due to the large number of two-marker models that need to be
evaluated, searching for epistatic effects poses both computational
and statistical challenges. Whereas many human genome-wide
association studies test on the order of one million SNPs,
considering all pairs of SNPs amounts to approximately 500
billion tests, since the number of pairs of SNPs scales quadratically
with the number of markers. The large number of tests to perform
incurs a considerable computational burden, although this
challenge is being increasingly addressed. Computational solutions
include parallelizing the computations [11], graphics hardware
based computing [12], and implementing approximations for case-
control studies [13]. Therefore, ultimately the most pressing
problem is how to handle the statistical issue of multiple testing. As
a result of performing so many tests, a very stringent type I error
threshold is needed to prevent selection of false positives.
However, at such a threshold many true positives are being
missed. In addition, epistatic tests have a complex dependency
structure, which requires cumbersome permutation procedures in
order to properly assess the type I error rate.
The multiple testing problem has been addressed in previous
expression quantitative trait locus (eQTL) studies by reducing the
number of SNPs tested for association with gene expression
phenotypes. To search for genetic variants which are associated
with a particular gene expression level, many researchers have
restricted the search to those variants proximal to the gene in
question, knowns as cis eQTLs [14,15]. In contrast, to search for
non-proximal variants associated with gene expression (trans
eQTLs), approaches may select SNPs hypothesized as more likely
to affect gene expression such as non-synonymous SNPs, cis
associated SNPs to any gene, or splicing SNPs [14]. Other
methods weight genetic variants based on their regulatory features,
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position and type of genetic polymorphisms [16]. In vitro
information about the DNA-binding specificity of a transcription
factor can be included to map loci [17]. Moreover, integration of
multiple data types has been suggested to aid in detecting and
interpreting regulatory variants [18,19].
Similar methods have been proposed to reduce the number of
SNP pairs to detect epistasis. A marginal-by-genomewide
approach was proposed, in which SNP pairs are chosen such that
at least one SNP has a relatively strong marginal association with
the trait [20,21]. Other approaches have used protein-protein
interaction information from STRING [22] to prioritize SNP
pairs [9] and CNV pairs [23]. Another paper proposed using
either disease-dependent information based on previously detected
associations or using existing biological databases to define
candidate SNP pairs to test for epistasis [10]. Additionally, a
specific biological hypothesis, such as the interaction between
regulatory and protein-coding variants [24], can drive an
approach to studying epistatic effects.
While many strategies to detect epistasis effects have been
proposed and tested for specific phenotypes, so far there has been
no systematic attempt to compare their performance using real
data. In this work we present a comparative analysis of various
strategies. To evaluate any approach we first sought for a measure
of performance, identifying the false discovery rate (FDR) as the
most relevant indicator. The immense computational burden was
overcome using optimized computations and massive parallel
computing [11] on a large computer cluster (www.vital-it.ch). In
terms of data, it is clear that when considering a single trait it is
difficult to assess which strategy for selecting SNP pairs may be
optimal. Therefore we made use of gene expression traits
generated in linkage and eQTL studies, since these data include
thousands of traits, of which a large fraction is known to have a
strong genetic component. Specifically, we first analyzed data from
a yeast linkage study [25], encouraged by reports from several
studies identifying interacting loci [3,26] and the smaller
complexity compared to human data. We found that information
from marginal associations is more informative than using
STRING annotations. However, using the data from a human
eQTL study, we did not find convincing evidence for systemat-
ically improved performance of strategies relying on marginal
associations or gene annotations. Although we had considerable
computational resources at our disposal, we were faced with
considerable study limitations. Nevertheless, we found several
putative associations when testing a small number of SNPs with
strong marginal effects.
Results
We first used data from a yeast linkage study, consisting of 112
segregants derived from a cross of a yeast lab strain (S288C) and a
wild isolate, as described in [25], to study epistatic effects. We
initially attempted a naı ¨ve method to detect epistatic effects which
searches over all possible SNP pairs. For 2,931 markers, there
were a total of 4,293,915 SNP pairs. Using 10,000 permutations,
at cutoffs defined by the 1% and 0.1% quantile of the permutation
statistics (see Methods), we estimated an FDR of 96% and 99%,
respectively. The number of SNP pairs selected at these thresholds
closely matches the number of SNP pairs expected by chance.
Next, we tried several different strategies to reduce the number
of SNP pairs under consideration, marginal-by-marginal (MM),
marginal-by-genomewide (MG) and STRING (ST) strategies. We
test the epistasis model (see Methods) using a subset of SNP pairs
defined by each strategy. The MM strategy selects a set of SNP
pairs such that both SNPs in the pair are associated with the trait
at a given significance level, determined from the one-dimensional
regression model (see Methods). The MG strategy selects a set of
SNP pairs such that at least one SNP in the pair is associated with
the trait at a given significance level. The ST strategy selects pairs
of genes with corresponding protein-protein interactions in the
STRING database determined by a given significance threshold.
The strategy includes all SNP pairs that map to a gene pair.
We compared the different strategies by comparing the
estimated FDR as shown in Figure 1A. We define a p-value
cutoff by the 0.1% quantile of the permutation statistics which
fixes the expected number of false positives. We found that overall
the MM and MG strategies tend to have lower FDRs than the ST
strategy. We can also observe that for the MM and MG strategies,
as the number of tests increases, the FDR tends to increase. This
trend is due to the statistical issue of multiple testing, reflecting that
as the number of tests increases it becomes difficult to distinguish
the significance of true interaction effects from those expected by
chance. Indeed, we found that selecting a very small number of
marginal SNPs gives the smallest FDR.
We also compared the strategiesby comparing their performance
to an appropriate control strategy (MM
0,M G
0 and ST
0,
respectively; see Methods and Figure 2 for further details). The
goal is to assess whether the information in the candidate strategies
aids in the detection of epistatic effects. The performance relative to
500 randomly chosen respective controls is given in Figure 1B–D.
Both the MM and MG strategies result in a lower FDR than the
random control (p=0.07, p=0.17, respectively for approximately
3,000 tests). In contrast, the ST strategy does not outperform the
random control at any significance threshold (p=1.0). The FDR as
a function of the p-value cutoff is shown in Figure S1.
The best performing strategy was the MM strategy. The FDR
was 39.7%, with 10 hits selected at this cutoff, whereas the expected
number of false positives was below four. A plot of the most
significant interaction from the MM strategy is given in Figure 3.
We then tried a similar approach to systematically compare the
performance of different strategies for human data. However, we
were faced with considerable study limitations, including larger
computational and statistical complexity and stronger environ-
mental effects. We chose a restricted set of 297,153 HapMap SNPs
(see Methods), corresponding to 44 billion possible SNP pairs. As
in yeast, we performed permutation tests to assess the significance
of the interaction test statistics. However, even with our large
computational resources we were only able to perform 1,000
permutations. With fewer permutations, we are required to use a
less stringent p-value threshold to assess significance of the results.
As a result, we had less power to separate out the strongest signals
from noise. We note that in the analysis of yeast, using the same
(1%) quantile cut-off as for the human data (instead of the 0.1%
quantile), we do not observe improved performance of the MM or
MG strategies compared to the ST strategy, with all strategies
giving FDRs of 78–100%.
Applyingthe naı ¨ve method to detect epistaticeffects which searches
over all possible SNP pairs, at a p-value cutoff defined by the 1%
quantile of the permutation statistics, we find an FDR of 82%. Thus,
of the 12 results selected, only about two are expected to be true.
Next, we compared the performance of MM, MG and ST
strategies. As shown in Figure 4, we do not see any trend in
performance suggesting that any of the MM, MG or ST strategies
achieve superior performance.
In order to facilitate the computation of a larger number of
permutations, we decided to evaluate the MM strategy using a
very limited set of SNPs. For such a small set of SNPs it was
therefore possible to perform 10,000 permutations. We applied the
Strategies to Detect Epistasis from eQTL Data
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each gene expression trait, corresponding to 1.2 million SNP pairs.
We assessed the significance using 10,000 permutation tests. At the
0.1% quantile of the permutation statistics we estimate an FDR of
0.33, detecting three putative hits of which approximately one is
expected by chance (Figure S2).
Details of the genes and SNPs associated epistatically are given in
Table 1. A plot of the FDR at different p-value thresholds is given in
FigureS3.Wetested theepistaticassociationwithexpressionlevelsof
HLA-DRB1 in other populations obtaining p-values of 0.0055,
0.0098, 0.015, 0.00012, 0.93, 0.40, 0.59 for CHB, JPT, GIH, MEX,
LWK, MKK and YRI, respectively, indicating that the interaction
replicates well across non-African populations (see also Figure S4).
We estimate the percent variance explained by the epistasis term to
be 9.3%, 7.9%, 7.0%, and 28.7% in CHB, JPT, GIH, and MEX,
respectively.Weaskedwhethertheinteraction effectforHLA-DRB1
woulddisappearifwetakeintoaccountdominantorrecessiveeffects.
We found that the interaction remains significant (p=1.631e-11,
CEU).BothSNPsfallwithinCNV regionsbased ontheDatabasefor
Genomic Variants [27]. However, the Hardy-Weinberg p-values are
not significant (p=0.575, p=0.646) indicating that these SNPs are
not likely to fall into the copy number variant region.
Figure 1. Comparison of the FDR (determined at cutoffs corresponding to the 0.1% quantile of permutation p-values) for detecting
interactions in yeast gene expression data among the different subset strategies. (A) The FDR is plotted against the number of SNP pairs
for MM, MG and ST in red, green and blue, respectively. (B–D) The FDR is shown for MM, MG and ST strategies compared to 500 MM
0,M G
0 and ST
0
control strategies, respectively. Significance values are computed as the proportion of control strategies with FDR as low or lower. (B) Significance
values 0.052, 0.072, 0.088, 0.05, 0.16, 0.54, 1.0, 1.0 and 0.15. (C) Significance values 0.17, 0.17, 0.048, 0.13, 0.32, 1.0, 1.0 and 0.16. (D) Significance values
1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0.
doi:10.1371/journal.pone.0028415.g001
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We compared several strategies to derive a subset of candidate
SNP pairs to test for epistatic effects. We found that, in yeast,
strategies making use of marginal association information out-
perform the STRING strategy which relies solely on annotations
of protein-protein interactions. We found that the MM strategy
can give rise to a set of epistatic effects with a lower proportion of
false positives than naı ¨vely testing all possible SNP pairs. This fact
indicates that SNP pairs with the largest marginal associations tend
to be enriched for epistatic effects.
In our comparison among the different strategies in human, we
did not find evidence that one strategy outperforms another.
However, our ability to differentiate between the strategies has
Figure 2. Illustration of comparisons between subset strategies and control strategies for the MM strategy. A subset strategy is applied
to both gene expression measurements and randomly permuted measurements. The gene expression measurements define the number of hits at a
given p-value threshold while the permutations are used to estimate the expected number of false positives, giving rise to an estimate of the FDR.
doi:10.1371/journal.pone.0028415.g002
Figure 3. The data supporting the most significant interaction
from the MM strategy is shown here. Capital letter markers refer to
RM11; lowercase letter markers refer to BY4716 (S288c). Blue bars mark
the model predicted expression levels at each combination of genetic
markers, green dots show the observed mean expression levels, and
grey bars show the standard deviation.
doi:10.1371/journal.pone.0028415.g003
Figure 4. Comparison of the FDR (determined at cutoffs
corresponding to the 0.1% quantile of permutation p-values)
for detecting interactions in human gene expression data
among the different subset strategies. The FDR is plotted against
the number of SNP pairs for MM, MG and ST in red, green and blue,
respectively.
doi:10.1371/journal.pone.0028415.g004
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human compared to yeast significantly increased the computa-
tional time (indeed we required several thousand CPU days on the
high-performance computing facility VITAL-IT (http://www.
vital-it.ch)). We examined only a subset of SNPs and we were only
able to perform 1,000 permutations for the permutation test
whereas we used 10,000 permutations in yeast. Furthermore, a
dataset with larger number of individuals would provide more
power in the multiple testing setting to detect epistatic effects.
Applying the MM strategy to a limited set of SNPs, we were
able to detect one interaction in the CEU data which replicated in
several non-African populations. Therefore, this finding likely
represents a true interaction. A pair of SNPs near the HLA-DRA
gene showed an epistatic effect on the expression levels of HLA-
DRB1. Furthermore, including the epistatic relationship in the
model of genetic effects on HLA-DRB1 expression increases the
percent of explained variance by 7–28%.
However, the MM strategy did not result in many positive
findings. The limited success may be due to the increased
complexity of human data relative to yeast or perhaps due to
smaller marginal effects in human than in yeast. Environmental
variation may also play a large role for humans whereas the yeast
strains were grown in a tightly controlled environment. Future
studies, particularly with larger sample sizes, would be worthwhile
to determine the limitations of the MM strategy.
One of the drawbacks to the MM strategy is that by definition it
can only identify interactions between SNPs with marginal
associations, while it misses non-marginally associated SNPs which
may have epistatic associations. In contrast, the MG approach in
principle allows for identification of new SNPs involved in genetic
associations through epistasis, as long as this interaction involved
another SNP with a statistically significant marginal association.
Thus the fact that the performance of MM and MG are not very
different, would perhaps point to MG as the best compromise
between power and the ability to identify novel interesting loci.
Although we found that marginal associations are more
informative for identifying epistasis than information from the
STRING database, future approaches may benefit from incorpo-
rating biological information in more sophisticated ways. Using
knowledge of transcription factors which regulate the gene’s
expression patterns, weighting SNPs based on their properties (i.e.
synonymous, non-synonymous, cross-species conservation score)
or using mutual information from several markers at once for case-
control studies [28] may also prove worthwhile.
Methods
Data
Yeast. The yeast data were taken from 112 segregants derived
from a cross of a yeast lab strain (S288C) and a wild isolate, as
described in [25].
Gene expression measurements were subjected to the following
exclusions and pre-processing. We excluded genes not included in
the list provided by [29]. We required the gene expression values
to have at least 90% non-missing values across the segregants. We
normalized the data by subtracting the mean value calculated
across all spots on the array and averaged the gene expression
from the dye-swapped experiments. Log gene expression values
were normal quantile transformed. Missing values were set to zero.
The transformation to normal distribution was done for
computational ease for permutation testing (see below). A total
of 3,970 genes were included in our analysis.
We used genotype measurements from all 2,931 quality-
controlled markers as described in [25].
Human. We used genotypic data from several HapMap
populations (CEU, n=109; CHB, n=80; GIH, n=82; JPT,
n=82; LWK, n=83; MEX, n=45; MKK, n=138; YRI, n=108)
[30] in combination with expression profiles for lymphoblastoid
cell lines generated from HapMap participants (commercial
source: Coriell). Gene expression transcript levels were measured
using Illumina’s commercial whole genome expression array,
Sentrix Human-6 Expression BeadChip version 2 (E. Dermitzakis,
personal communication). We focused on data from the CEU
panel since it has been well studied and many cis and trans effects
have been reported [14].
We studied a subset of CEU candidate genes selected to have
expression above background levels (mean transcript expression
above average), highvariation inexpression (standard deviation$0.5)
and a moderate number of genetic associations, using log transformed
expression values. For each gene, we counted the number of marginal
associations across the genome with p-values below 10
25.W e
included genes with at least the average number of such associations.
The selection resulted in 989 gene expression probes.
The genotypes consist of 1.2 million HapMap SNPs. For the
comparison of multiple strategies across different numbers of SNP
pairs, we selected a subset of SNPs which uniquely mapped to
gene regions and required minor allele frequency .0.20
(N=297,153, see below). For the MM analysis (see Subset
Selection Strategies below) we only required a minor allele
frequency .0.05 (N=1,223,296).
Evaluation of Subset Strategies
A subset strategy defines a subset of SNP pairs which are tested
for epistatic associations with a given set of phenotypes. For any
given strategy we ask how many gene expression traits have at least
one significantly associated epistasis effect. Hence, for each gene
expression trait, it suffices to consider the minimum p-value across
a SNP pair subset.
We assess the significance of the minimum p-value through
permutation tests. Each permutation test consists of randomly
permutingthephenotypevalues.Wetransformeachgeneexpression
phenotype via the normal quantile transformation so that all
phenotypes have the same distribution. Therefore, a single set of
permutations can be used to compare with all gene expression traits.
For any subset strategy we compare results from measured
gene expression to results from permuted phenotypes. We chose a
p-value cutoff in order to fix the expected number of false positives
under the null hypothesis that no interaction effects exist. We then
calculated the FDR, as used in [14]. We found this method to be
useful to assess moderate FDR values, since no hits would be found
for very stringent FDR cutoffs (such as 0.05). For yeast, we chose a
p-value cutoff determined from the 0.1% quantile of the
permutation values, using 10,000 permutations. This corresponds
to the 10
th smallest of the 10,000 p-values. For the strategy
comparison in human, due to computational considerations, we
Table 1. Details of the two hits discovered by the MM
strategy in a human CEU eQTL dataset.
Gene Probe Snp1 Snp2 P-value
HLA-DRB1 ILMN_20550_7330093 rs3763313 rs3129883 1.79e-14
HLA-DRB5 ILMN_3178_4390692 rs984778 rs206017 1.19e-13
IFIT3 ILMN_1944_2690452 rs2197025 rs2031339 9.13e-12
The FDR is estimated at 49%.
doi:10.1371/journal.pone.0028415.t001
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determined from the 1% quantile of the permutation values,
corresponding to the 10
th smallest of 1,000 p-values.
Subset Strategies
The marginal–by-marginal (MM) strategy selects a subset of
SNP pairs such that both SNPs have marginal effects at a given
significance threshold. The marginal-by-genomewide (MG) strat-
egy selects a subset of SNP pairs such that at least one SNP has a
marginal effect at a given significance threshold. The STRING
(ST) strategy selects pairs of genes from the STRING database
with scores above a given threshold. Larger scores indicate
stronger evidence of a physical interaction between the corre-
sponding proteins. STRING protein pairs are mapped to gene
pairs which are subsequently mapped to corresponding SNP pairs.
For a SNP pair subset strategy, we define an appropriate control
strategy (MM
0,M G
0 and ST
0, respectively) whose aim is to ignore
information used in the strategy’s selection of SNP pairs. Both
MM
0 and MG
0 strategies use marginally associated SNPs to a
random phenotype. The MM
0 strategy consists of SNP pairs such
that both SNPs are marginally associated with the random
phenotype. The MG
0 strategy selects SNP pairs such that at least
one SNP is marginally associated with the random phenotype.
The ST
0 strategy randomly chooses gene pairs such that both
genes belong to the STRING database but are not necessarily
connected in STRING. The gene pairs are subsequently mapped
to corresponding SNP pairs.
The performance of the control strategy is evaluated on both
the measured gene expression data and the permuted data, and
the performance is compared between the two to estimate the
FDR. In yeast, we carried out 500 analyses using the control.
Mapping SNPs to Genes
In yeast we used the annotation provided by [25] to map SNPs
directly to genes. We do not map upstream or downstream SNPs
to the genes, but these SNPs are considered indirectly due to the
strong linkage disequilibrium with surrounding markers arising
from the linkage study. Note that only a subset of SNPs map to
genes. Therefore we performed the STRING strategy on a smaller
SNP subset than the MM and MG strategies. MM and MG
strategies were also performed on the restricted subset of SNPs
that map to genes in the STRING database (see Figure S5).
For the human data we mapped SNPs to genes provided they
fell within 1 kb upstream or downstream of the transcription start
site or within the gene region. We excluded SNPs mapping to
multiple genes (N=3,169) to enable easier mapping from
STRING gene pairs to a set of SNP pairs.
Tests of Genetic Association
Genetic association tests were carried out for marginal and
epistatic models. The marginal model associates a phenotype, y,
with the value of a single SNP, x. For haploid yeast genotypes x
takes the value of either 0 or 1, whereas for diploid human
genotypes x takes the value of 0, 1 or 2. We employ a simple
normal linear model, y~azbxze, and assess the association
between a SNP and a phenotype based on the significance of the b
term. Marginal tests were carried out using PLINK [31].
The epistasis model includes effects of two SNPs, x1 and x2.
Again we use a normal linear model y~azb1x1zb2x2z
b12x1x2ze. We assess the epistatic association between a pair of
SNPs and a phenotype based on the significance of the b12 term.
Epistasis tests were carried out using the FastEpistasis software
[11].
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Supporting Information
Figure S1 We plot the FDR for different p-value cutoffs, starting
from the 0.1% quantile for the MM, MG and ST strategies
separately.
(PDF)
Figure S2 Shown here is the fit of the epistasis model for the
three interactions detected by the MM strategy, using 10,000
permutations. Gene expression phenotypes (A) HLA-DRB1, (B)
HLA-DRB5 and (C) IFIT3.
(EPS)
Figure S3 We plot the FDR results from the MM strategy (top
5000 marginally associated SNPs) for different p-value cutoffs,
starting from the 0.1% quantile.
(PDF)
Figure S4 Shown here is the fit of the epistasis model for the top
interaction detected by the MM strategy, using 10,000 permuta-
tions. The fit is shown for several populations for which the effect
replicated (A) CHB, (B) JPT, (C) GIH and (D) MEX.
(EPS)
Figure S5 Comparison of the FDR (determined at cutoffs
corresponding to the 0.1% quantile of permutation p-values) for
detecting interactions in yeast gene expression data among the
different subset strategies. The analysis is restricted to SNPs
mapping to genes in STRING. The FDR is plotted against the
number of SNP pairs for MM, MG and ST in red, green and blue,
respectively.
(PDF)
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